Start Page
Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
Κλίκ για μεγέθυνση
Παρασκευή 20 Αύγ 2021
Glycosylated hemoglobin (HbA1c) has been the sole surrogate marker for assessing diabetic complications. However, consistently reported limitations of HbA1c are that it lacks detailed information on short-term glycemic control and can be easily interfered with by various clinical conditions such as anemia, pregnancy, or liver disease. Thus, HbA1c alone may not represent the real glycemic status of a patient. The advancement of continuous glucose monitoring (CGM) has enabled both patients and healthcare providers to monitor glucose trends for a whole single day, which is not possible with HbA1c. This has allowed for the development of core metrics such as time spent in time in range (TIR), hyperglycemia, or hypoglycemia, and glycemic variability. Among the 10 core metrics, TIR is reported to represent overall glycemic control better than HbA1c alone.

Διαβάστε ολόκληρο το άρθρο εδώ.

Γραμματεία Συνεδρίου:

  +30 2611 100 410   /    info@endorama.gr


Κάντε την εγγραφή σας στο Newsletter μας:


Login / Sitemap

© Copyright 2020 - 2022 Ενδόραμα - Ενδοκρινολογία Διαβητολογία Μεταβολισμός